Brief: Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg
June 12 (Reuters) - Getinge AB GETIb.ST :
* GETINGE: GRANTED U.S. FDA 510(K) CLEARANCE FOR ITS
INNOVATIVE
CLINICAL DECISION SUPPORT SOFTWARE TALIS +ACG
Source text for Eikon: ID:
Further company coverage: GETIb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million